Novo Nordisk A/S (NVO)
128.80
+0.75
(+0.59%)
USD |
NYSE |
Mar 28, 09:55
Novo Nordisk Cash from Investing (TTM): -6.373B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -6.373B |
September 30, 2023 | -6.295B |
June 30, 2023 | -4.987B |
March 31, 2023 | -4.203B |
December 31, 2022 | -3.532B |
September 30, 2022 | -4.783B |
June 30, 2022 | -4.871B |
March 31, 2022 | -4.752B |
December 31, 2021 | -5.029B |
September 30, 2021 | -3.684B |
June 30, 2021 | -3.957B |
March 31, 2021 | -3.691B |
December 31, 2020 | -3.438B |
September 30, 2020 | -1.987B |
June 30, 2020 | -1.357B |
March 31, 2020 | -1.576B |
December 31, 2019 | -1.726B |
September 30, 2019 | -1.905B |
June 30, 2019 | -1.975B |
March 31, 2019 | -1.949B |
December 31, 2018 | -1.914B |
September 30, 2018 | -1.706B |
June 30, 2018 | -1.611B |
March 31, 2018 | -1.326B |
December 31, 2017 | -1.000B |
Date | Value |
---|---|
September 30, 2017 | -939.19M |
June 30, 2017 | -1.009B |
March 31, 2017 | -870.94M |
December 31, 2016 | -1.009B |
September 30, 2016 | -1.307B |
June 30, 2016 | -1.398B |
March 31, 2016 | -1.424B |
December 31, 2015 | -907.22M |
September 30, 2015 | -490.48M |
June 30, 2015 | -187.47M |
March 31, 2015 | -165.51M |
December 31, 2014 | -368.14M |
September 30, 2014 | -180.14M |
June 30, 2014 | -348.92M |
March 31, 2014 | -347.84M |
December 31, 2013 | -493.76M |
September 30, 2013 | -691.26M |
June 30, 2013 | -630.28M |
March 31, 2013 | -534.54M |
December 31, 2012 | -702.86M |
September 30, 2012 | -882.14M |
June 30, 2012 | -700.34M |
March 31, 2012 | -864.76M |
December 31, 2011 | -646.16M |
September 30, 2011 | -827.89M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-6.373B
Minimum
Dec 2023
-1.357B
Maximum
Jun 2020
-3.604B
Average
-3.687B
Median
Cash from Investing (TTM) Benchmarks
Amgen Inc | -26.20B |
Vertex Pharmaceuticals Inc | -3.142B |
Sarepta Therapeutics Inc | -165.80M |
Viking Therapeutics Inc | -179.09M |
CytomX Therapeutics Inc | -150.67M |